Fragment-based drug discovery (FBDD) has emerged as a transformative approach in medicinal chemistry by focusing on the identification of small chemical fragments that bind to biologically relevant ...
Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...
The Institute of Cancer Research and Enamine Ltd. have announced a new research collaboration aimed at broadening the tools available for researchers working in fragment-based drug discovery (FBDD).
Evotec AG has announced that the Company and Ono Pharmaceutical Co., Ltd. signed a new drug discovery agreement targeting a protease chosen by Ono. The collaboration applies Evotec’s proprietary ...
A recent study shows that computer algorithms can be used to find molecules that can be developed into anti-inflammatory ...
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high ...
WPRI.com is provided by Nexstar Media Group, Inc., and uses the My Nexstar sign-in, which works across our media network. Nexstar Media Group, Inc. is a leading, diversified media ...
BUFFALO, N.Y. — How can a drug be designed to only target proteins that are already switched off? Does whether a drug works depend on where its molecule fragments are linked together? Is drug potency ...
In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim ...
WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leader in AI-powered solutions for drug discovery and development, has been honored with the “AI-based Drug Discovery Solution of the Year” award in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback